These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15319722)

  • 1. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.
    Matas AJ; Kandaswamy R; Humar A; Payne WD; Dunn DL; Najarian JS; Gruessner RW; Gillingham KJ; McHugh LE; Sutherland DE
    Ann Surg; 2004 Sep; 240(3):510-6; discussion 516-7. PubMed ID: 15319722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone-free maintenance immunosuppression-a 5-year experience.
    Matas AJ; Kandaswamy R; Gillingham KJ; McHugh L; Ibrahim H; Kasiske B; Humar A
    Am J Transplant; 2005 Oct; 5(10):2473-8. PubMed ID: 16162197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.
    Rizzari MD; Suszynski TM; Gillingham KJ; Dunn TB; Ibrahim HN; Payne WD; Chinnakotla S; Finger EB; Sutherland DE; Kandaswamy R; Najarian JS; Pruett TL; Kukla A; Spong R; Matas AJ
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):494-503. PubMed ID: 22282482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients.
    Khwaja K; Asolati M; Harmon J; Melancon JK; Dunn T; Gillingham K; Kandaswamy R; Humar A; Gruessner R; Payne W; Najarian J; Dunn D; Sutherland D; Matas AJ
    Am J Transplant; 2004 Jun; 4(6):980-7. PubMed ID: 15147433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota.
    Serrano OK; Kandaswamy R; Gillingham K; Chinnakotla S; Dunn TB; Finger E; Payne W; Ibrahim H; Kukla A; Spong R; Issa N; Pruett TL; Matas A
    Transplantation; 2017 Oct; 101(10):2590-2598. PubMed ID: 28376034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results.
    Chavers BM; Chang YC; Gillingham KJ; Matas A
    Transplantation; 2009 Jul; 88(2):237-41. PubMed ID: 19623020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A; Pelletier RP; Henry ML; Ferguson RM
    Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
    Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
    Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
    Gotti E; Perico N; Perna A; Gaspari F; Cattaneo D; Caruso R; Ferrari S; Stucchi N; Marchetti G; Abbate M; Remuzzi G
    J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone-free maintenance immunosuppression in obese kidney transplant recipients.
    Matas AJ; Vock DM
    Clin Transplant; 2019 Oct; 33(10):e13668. PubMed ID: 31310030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.
    Matas AJ; Ramcharan T; Paraskevas S; Gillingham KJ; Dunn DL; Gruessner RW; Humar A; Kandaswamy R; Najarian JS; Payne WD; Sutherland DE
    Am J Transplant; 2001 Sep; 1(3):278-83. PubMed ID: 12102262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
    Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
    Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.
    Rajab A; Pelletier RP; Ferguson RM; Elkhammas EA; Bumgardner GL; Henry ML
    Transplantation; 2007 Nov; 84(9):1131-7. PubMed ID: 17998868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
    Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.